RedHill Biopharma Ltd. (RDHL)
NASDAQ: RDHL · Real-Time Price · USD
2.030
+0.030 (1.50%)
May 12, 2025, 4:00 PM - Market closed
RedHill Biopharma Market Cap
RedHill Biopharma has a market cap or net worth of $3.50 million as of May 12, 2025. Its market cap has decreased by -73.85% in one year.
Market Cap
3.50M
Enterprise Value
-756.99K
1-Year Change
-73.85%
Ranking
Category
Stock Price
$2.03
Market Cap Chart
Since January 7, 2013, RedHill Biopharma's market cap has decreased from $58.80M to $3.50M, a decrease of -94.04%. That is a compound annual growth rate of -20.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 2.60M | -67.09% |
| Dec 31, 2024 | 7.90M | 68.09% |
| Dec 29, 2023 | 4.70M | -47.78% |
| Dec 30, 2022 | 9.00M | -92.54% |
| Dec 31, 2021 | 120.70M | -57.65% |
| Dec 31, 2020 | 285.00M | 65.51% |
| Dec 31, 2019 | 172.20M | 45.81% |
| Dec 31, 2018 | 118.10M | 34.66% |
| Dec 29, 2017 | 87.70M | -34.06% |
| Dec 30, 2016 | 133.00M | 17.49% |
| Dec 31, 2015 | 113.20M | 31.93% |
| Dec 31, 2014 | 85.80M | 37.28% |
| Dec 31, 2013 | 62.50M | 6.29% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |